Could anti-obesity drugs transform healthcare? Jenny Chang, portfolio manager with Goldman Sachs Asset Management, separates the signal from the noise.
Our signature newsletter with insights and analysis from across the firm
By submitting this information, you agree that the information you are providing is subject to Goldman Sachs’ privacy policy and Terms of Use. You consent to receive our newletter via email.